Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Clinical trial NCT07024680 · RECRUITING

Trial details

NCT number: NCT07024680
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Papillary Renal Cell Carcinoma

Start date: 2025-03-31
Primary completion: 2026-07-14
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.